Early Detection Research Network

Pecot MALDI MS signature + clinical and imaging data

Aliases:
This biomarker is also known as:
  • Pecot MALDI MS signature + clinical and imaging data,

Description…

A serum proteomic signature of seven features identified by MALDI MS was previously identified (see "Yildiz MALDI MS signature for lung cancer"). The serum signature was associated with the diagnosis of lung cancer independently of gender, smoking status, smoking pack-years, and C-reactive protein levels. Here the signature is applied to cohorts presenting with one or more lung nodules discovered by clinical evaluation and chest CT.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Curated
HGNC Name:

Panel Details

No member markers defined for this panel.

The following organs have data associated with this biomarker…

Attributes

Phase: One
QA State: Curated

Overview

This blood biomarker signature may add value to the clinical and chest CT evaluation of indeterminate lung nodules.

Performance Comment

Traditional test results (clinical and radiographic data) in combination with this biomarker signature more accurately classify individuals with lung nodules into cancer vs. no cancer categories.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

No associated publications found.

No other associated resources found.